Boehringer Ingelheim Aptivus

Product Details

Indicated for combination antiretroviral treatment of HIV-1-infected patients, co-administered with 200 mg of ritonavir, who are treatment-experienced and infected with HIV-1 strains resistant to more than one protease inhibitor.

Get Reviews Widget

Leave a review

You may also like...